Profound Medical Corp (PROF) - Kapitalizatsiyaning foydaga nisbati

Profound Medical (PROF) korporativ emblemasi va logotipi

Profound Medical Corp. (PROF) barqaror rivojlanish tamoyillariga amal qiladi va ultratovush terapiyasi tizimlarini yaratish jarayonida atrof-muhitga bo'lgan ta'sirni minimallashtiradi. Ushbu narxlar grafigi PE koeffitsiyenti -8.10 bo'lgan aktivning dinamikasini aks ettiradi. Ablyatsiya platformalari uchun komponentlarning muntazam yetkazib berilishi barqaror pul oqimini ta'minlaydi. Bundan tashqari, minimal invaziv davolashga bo'lgan talab iqtisodiy tebranishlarga bog'liq bo'lmagani sababli, biznes himoyaviy xususiyatlarga ega.

Profound Medical Corp (PROF): Narx-foyda koeffitsiyenti 25.09.2023dan 10.11.2026gacha

Profound Medical Corp (PROF) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning umumiy tahlili:profoundmedical.com - PROF
Profound Medical Corp. ishlab chiqargan mahsulot

Investorlar Profound Medical Corp. (PROF) kompaniyasining barqarorligini kelajakdagi kapitalizatsiya va past baholanganlik xatarlari prizmasi orqali bahlamoqdalar. Ultratovush ablatsiyasi uchun sarflanadigan materiallar va dasturiy ta'minotning yuqori marjasi uzoq muddatli pul oqimini yaratib, biznesdagi tebranishlarni kamaytiradi. Foyda ko'rsatkichi (P/E) bir dollarlik foyda narxini aks ettirib, kompaniyaning P/E koeffitsiyentidagi o'zgarishni aniq namoyish etadi. Ushbu metrikaning tahlili aktivning yangi o'sish sikli oldidan konsolidatsiya bosqichini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

dexcom.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori PEN|NOVT - Kapitalizatsiyaning foydaga nisbati|Haemonetics Corp. - Narx-foyda koeffitsiyenti|P/E multiplikatori Inspire Medical Systems Inc INSP|PRCT: Narx-foyda koeffitsiyenti|conmed.com - Bozor narxining sof foydaga nisbati|PLSE: P/E multiplikatori|INMD - Biznesning o‘zini qoplash muddati|PMI (Picard Medical Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Surmodics Inc. (SRDX)|Narx-foyda koeffitsiyenti SENS (Senseonics)|NPCE (neuropace.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Tactile Medical TCMD|SNWV - Narx-foyda koeffitsiyenti|Outset - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Electromed, Inc.|LNSR: P/E multiplikatori|Narx-foyda multiplikatori RCEL|BDMD (Baird Medical Investment Holdings) - P/E multiplikatori|EDAP Medical (EDAP) - Biznesning o‘zini qoplash muddati|P/E multiplikatori APYX|Narx-foyda koeffitsiyenti icecure-medical.com ICCM|P/E multiplikatori LUNG (Pulmonx)|P/E multiplikatori TELA Bio Inc. TELA|CTSO - Narxning foydaga nisbati|SRTS: Narxning foydaga nisbati|ZYXI (Zynex Inc) - Narx-foyda koeffitsiyenti|electroCore - Kompaniya qiymatining sof foydaga nisbati|RBOT (Vicarious Surgical Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Inspira Technologies Oxy B.H.N. Ltd IINN|Narxning foydaga nisbati SeaStar Medical (ICU)|iridex.com (IRIX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Intelligent Bio Solutions Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori Beyond Air Inc XAIR|Profusa Inc - P/E multiplikatori|Biznesning o‘zini qoplash muddati STRATA Skin Sciences SSKN|GlucoTrack, Inc. (GCTK) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati NAOV (nanovibronix.com)|Narxning foydaga nisbati Venus Concept Corp|Narx-foyda koeffitsiyenti Nuwellis Corp (NUWE)|P/E multiplikatori AEMD|ASXC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Avinger AVGR|BSGM: Narx-foyda multiplikatori|CUTR: Narx-foyda koeffitsiyenti|Know Labs Corporation - Bozor narxining sof foydaga nisbati|Inari Medical, Inc. (NARI) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati NVRO (nevro.com)|Narxning foydaga nisbati ReShape Lifesciences, Inc.|SILK: Kompaniya qiymatining sof foydaga nisbati